Key Factor Study for Generic Long-Acting PLGA Microspheres Based on a Reverse Engineering of Vivitrol(®)

The FDA (U.S. Food and Drug Administration) has approved only a negligible number of poly(lactide-co-glycolide) (PLGA)-based microsphere formulations, indicating the difficulty in developing a PLGA microsphere. A thorough understanding of microsphere formulations is essential to meet the challenge o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Yabing, Wang, Zengming, Wang, Dan, Lin, Xiaoming, Liu, Boshi, Zhang, Hui, Gao, Jing, Zheng, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975983/
https://www.ncbi.nlm.nih.gov/pubmed/33669152
http://dx.doi.org/10.3390/molecules26051247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975983/
https://www.ncbi.nlm.nih.gov/pubmed/33669152
http://dx.doi.org/10.3390/molecules26051247

Ejemplares similares